ConductScience.org, home

Paper15768340

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A and 2 others. Clin Infect Dis, 2005. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Papers, record 15768340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15768340

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
3.41
iCite
Revised in PubMed
2007-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Doab AAnna
2Treloar CCarla
3Dore GJGregory J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Health Knowledge, Attitudes, PracticeMajor topic
Health Services AccessibilityMajor topic
Hepatitis CMajor topic
Substance Abuse, IntravenousMajor topic
Adolescent
Adult
Australia
Demography
Female
Focus Groups
Humans
Interviews as Topic
Liver Diseases
Male
Pilot Projects
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
35991859Impact of comprehensive care on health care use among a cohort of marginalized people living with hepatitis C in Toronto.Can Liver J2020https://conductscience.org/library/papers/35991859PubMed
33616545Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.JMIR Mhealth Uhealth2021https://conductscience.org/library/papers/33616545PubMed
33560694Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.J Addict Med2022https://conductscience.org/library/papers/33560694PubMed
32522210Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.Harm Reduct J2020https://conductscience.org/library/papers/32522210PubMed
32009165Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.Clin Infect Dis2020https://conductscience.org/library/papers/32009165PubMed
31072401Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries.Harm Reduct J2019https://conductscience.org/library/papers/31072401PubMed
31068170The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010-2016.BMC Public Health2019https://conductscience.org/library/papers/31068170PubMed
30898327Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.J Subst Abuse Treat2019https://conductscience.org/library/papers/30898327PubMed
30107808From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, Canada.Harm Reduct J2018https://conductscience.org/library/papers/30107808PubMed
29679811Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.Int J Drug Policy2018https://conductscience.org/library/papers/29679811PubMed
29500784Hepatitis C Virus Knowledge Among Pregnant Women with Opioid Use Disorder.Matern Child Health J2018https://conductscience.org/library/papers/29500784PubMed
29096647Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.Harm Reduct J2017https://conductscience.org/library/papers/29096647PubMed
28721344Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.J Transl Int Med2017https://conductscience.org/library/papers/28721344PubMed
28652072Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.Int J Drug Policy2017https://conductscience.org/library/papers/28652072PubMed
28294492High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.HIV Med2017https://conductscience.org/library/papers/28294492PubMed
28070368The role of Aboriginal community attachment in promoting lifestyle changes after hepatitis C diagnosis.Health Psychol Open2015https://conductscience.org/library/papers/28070368PubMed
28018873Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.CMAJ Open2016https://conductscience.org/library/papers/28018873PubMed
27610937Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.Drug Alcohol Depend2016https://conductscience.org/library/papers/27610937PubMed
26900576Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment.Open Forum Infect Dis2016https://conductscience.org/library/papers/26900576PubMed
26503519Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.BMC Infect Dis2015https://conductscience.org/library/papers/26503519PubMed

See all 44 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15768340

GET https://conductscience.org/api/papers/v1/15768340/cited_by?page=2